DOV 22047
Alternative Names: DOV 22,047Latest Information Update: 17 Nov 2007
At a glance
- Originator DOV Pharmaceutical
- Class
- Mechanism of Action GABA A receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anxiety disorders
Most Recent Events
- 17 Nov 2007 Discontinued - Preclinical for Anxiety disorders in USA (unspecified route)
- 27 Mar 2006 No development reported - Preclinical for Anxiety disorders in USA (unspecified route)
- 11 Feb 2004 This compound is still in active development